4 Results for "

XMT1519

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "XMT1519" in MCE Product Catalog:

Cat. No.: HY-148067
CAS No.: 2720500-19-4
Purity:  98.07%
Research Areas:  

Cancer

XMT-1519 conjugate-1 (compound 31) is part of the drug-linker conjugate for ADC and can be conjugated with the HER-2 monoclonal antibody Calotatug (XMT-1519) (HY-P990909) for the synthesis of ADC .
loading...
    loading...
Cat. No.: HY-164919
CAS No.: 2847102-44-5
Synonyms: XMT-2056
Calotatug ginistinag (XMT-2056) is an antibody-drug conjugate (ADC) targeting HER2, linked to a payload composed of XMT-1519 conjugate-1 (HY-148067) and STING agonist-20 (HY-148068). Calotatug ginistinag activates the STING signaling pathway in tumor cells and tumor-resident immune cells, induces the production of type I interferons and cytokines (CXCL10, IFN-β, IL-6, TNF-α, triggers innate anti-tumor immune responses, and exerts a bystander effect. Calotatug ginistinag exhibits efficacy against HER2-expressing cancer cells in co-culture with PBMCs. Calotatug ginistinag induces tumor regression and reduces systemic inflammation in various tumor models. Combination treatment with Calotatug ginistinag, Trastuzumab (HY-P9907) and T-DXd (HY-138298) yields benefits. Calotatug ginistinag can be used in studies related to HER2-expressing solid tumors such as breast cancer, gastric cancer and ovarian cancer .
loading...
    loading...
Cat. No.: HY-148067A
Research Areas:  

Cancer

XMT-1519 conjugate-1 TFA (compound 31) is part of the drug-linker conjugate for ADC and can be conjugated with the HER-2 monoclonal antibody Calotatug (XMT-1519) (HY-P990909) for the synthesis of ADC .
loading...
    loading...
Cat. No.: HY-P990909
CAS No.: 2254097-05-5
Synonyms: XMT-1519; XMT-1522 antibody

Target:  

EGFR

Research Areas:  

Inflammation/Immunology

HY-P990909 is an ERBB2-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...